References
1.
Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11. doi:10.1056/NEJMra0801454. PubMed PMID: 19246362; PMCID: 2927217.CrossRefPubMedPubMedCentral
2.
Schover LR. Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: a review. Med Pediatr Oncol. 1999;33(1):53–9.PubMed
3.
Ginsberg JP. New advances in fertility preservation for pediatric cancer patients. Curr Opin Pediatr. 2011;23(1):9–13. doi:10.1097/MOP.0b013e3283420fb6. PubMed PMID: 21157350; PMCID: 3095100.CrossRefPubMedPubMedCentral
4.
Caserta D, Ralli E, Matteucci E, Marci R, Moscarini M. Fertility preservation in female cancer patients: an emerging challenge for physicians. Panminerva Med. 2014;56(1):85–95.PubMed
5.
Anderson RA, Mitchell RT, Kelsey TW, Spears N, Telfer EE, Wallace WH. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol. 2015;3(7):556–67. doi:10.1016/S2213-8587(15)00039-X.CrossRefPubMed
6.
Levine JM, Kelvin JF, Quinn GP, Gracia CR. Infertility in reproductive-age female cancer survivors. Cancer. 2015;121(10):1532–9. doi:10.1002/cncr.29181.CrossRefPubMed
7.
Terenziani M, Piva L, Meazza C, Gandola L, Cefalo G, Merola M. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril. 2009;91(3):935 e15–6. doi:10.1016/j.fertnstert.2008.09.029.CrossRef
8.
Irtan S, Orbach D, Helfre S, Sarnacki S. Ovarian transposition in prepubescent and adolescent girls with cancer. Lancet Oncol. 2013;14(13):e601–8. doi:10.1016/S1470-2045(13)70288-2.CrossRefPubMed
9.
Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol. 2011;120(3):326–33. doi:10.1016/j.ygyno.2010.09.012.CrossRefPubMed
10.
Barton SE, Politch JA, Benson CB, Ginsburg ES, Gargiulo AR. Transabdominal follicular aspiration for oocyte retrieval in patients with ovaries inaccessible by transvaginal ultrasound. Fertil Steril. 2011;95(5):1773–6. doi:10.1016/j.fertnstert.2011.01.006.CrossRefPubMed
11.
Gomez-Hidalgo NR, Darin MC, Dalton H, Jhingran A, Fleming N, Brown J, Ramirez PT. Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic cancer: a report of two cases. J Minim Invasive Gynecol. 2015;22(4):687–90. doi:10.1016/j.jmig.2015.02.009.CrossRefPubMed
12.
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31(19):2500–10. doi:10.1200/JCO.2013.49.2678.CrossRef
13.
Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens Jr FL, Gelber RD, Hortobagyi GN, Albain KS, Investigators PS. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372(10):923–32. doi:10.1056/NEJMoa1413204. PubMed PMID: 25738668; PMCID: 4405231.CrossRefPubMedPubMedCentral
14.
Practice Committees of American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37–43. doi:10.1016/j.fertnstert.2012.09.028.CrossRef
15.
Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100(5):1214–23. doi:10.1016/j.fertnstert.2013.08.012.CrossRef
16.
Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90(5 Suppl):S188–93. doi:10.1016/j.fertnstert.2008.08.034.
17.
Sonmezer M, Turkcuoglu I, Coskun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95(6):2125.e9–11. doi:10.1016/j.fertnstert.2011.01.030.CrossRef
18.
Keskin U, Ercan CM, Yilmaz A, Babacan A, Korkmaz C, Duru NK, Ergun A. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature. JPMA J Pak Med Assoc. 2014;64(7):830–2.PubMed
19.
Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673–80. doi:10.1016/j.fertnstert.2013.07.1992.CrossRefPubMed
